NLRP3 inflammasome activation and lung fibrosis caused by airborne fine particulate matter

Area of Science:

• Environmental Health
• Toxicology
• Immunology

Background:

• Airborne fine particulate matter (PM2.5) is linked to lung inflammation and fibrosis.
• The role of NLRP3 inflammasome activation in PM2.5 toxicity is understudied.
• PM2.5 contains nanomaterials that can activate the NLRP3 inflammasome.

Purpose of the Study:

• To investigate NLRP3 inflammasome activation and lung fibrosis induced by PM2.5.
• To elucidate the mechanisms of PM2.5-induced NLRP3 inflammasome activation.
• To assess the in vivo effects of PM2.5 exposure on lung inflammation and fibrosis.

Main Methods:

• In vitro studies using THP-1 cells to assess IL-1β secretion and inflammasome markers (ASC, NLRP3).
• Investigated PM2.5 cellular uptake pathways (endocytosis) and inflammasome activation mechanisms (cathepsin B, ROS, potassium efflux).
• In vivo studies exposing Balb/c mice to PM2.5 via oropharyngeal aspiration for 21 days.

Main Results:

• PM2.5 induced IL-1β secretion and NLRP3 inflammasome activation in THP-1 cells, inhibited by Z-YVAD-FMK.
• PM2.5 internalization occurred via multiple endocytic pathways.
• PM2.5 exposure in mice elevated IL-1β and TGF-β1 in BALF and caused collagen deposition, indicating lung fibrosis.

Conclusions:

• PM2.5 activates the NLRP3 inflammasome through endocytosis, cathepsin B release, ROS production, and potassium efflux.
• PM2.5 exposure induces lung inflammation and promotes pulmonary fibrosis in mice.
• Targeting NLRP3 inflammasome may offer therapeutic strategies for PM2.5-related lung diseases.